Anavex Life Sciences Corp
AVXL·Stocks·Biotechnology·United States·Nasdaq·USD
Price
Unknown
Today
-11.4%
YTD
-81.1%
About
Anavex is a healthcare business that develops drug candidates for the treatment of diseases of the central nervous system. Founded in 2004, the company has headquarters in New York City. Operating within the US, Anavex has been listed on the NASDAQ CM stock exchange under the ticker AVXL. Learn more about this instrument today and buy AVXL stock.
Price chart
Closing price history for AVXL (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-4.40
P/S (TTM)0.00
P/B (TTM)0.55
Market cap$61.88M
Cap tierMicro-cap
Industry avg P/E-5.49
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-12.80%
ROA-11.70%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$0.15
Free cash flow$-29.29M
Total debt$0.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.70
Employees34
Next earnings24 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.